NuvOx Pharma

About:

NuvOx Pharma is develops a nanotechnology for oxygen delivery, DDFPe that is phase II ready in stroke.

Website: http://www.nuvoxpharma.com/

Twitter/X: search

Top Investors: National Cancer Institute, National Institutes of Health, Keiretsu Capital, National Institute of Neurological Disorders and Stroke, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Description:

NuvOx Pharma develops a platform for drugs that upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ib ready).